LP
ALNY icon

Lloyd Park’s Alnylam Pharmaceuticals ALNY Stock Holding History

Lloyd Park’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$600K Hold
3,000
– – 0.74% 43
2022
Q2 		$438K Hold
3,000
– – 0.46% 52
2022
Q1 		$490K Hold
3,000
– – 0.54% 48
2021
Q4 		$509K Buy
+3,000
New +$558K 0.28% 76

Other funds holding ALNY

Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Lloyd Park's ALNY Position: Q3 2022 in Review

Lloyd Park held its Alnylam Pharmaceuticals (ALNY) position steady in Q3 2022 at 3,000 shares worth $600K. The position accounts for 0.74% of the portfolio, ranked #43.

Lloyd Park first reported a position in ALNY in Q4 2021 and has held it in 4 quarters since. 497 funds tracked by Wall St. Rank hold ALNY as of Q3 2022.

  • Lloyd Park held 3,000 shares of Alnylam Pharmaceuticals worth $600K as of Q3 2022.
  • Lloyd Park left its Alnylam Pharmaceuticals share count unchanged in Q3 2022.
  • Alnylam Pharmaceuticals made up 0.74% of Lloyd Park's portfolio in Q3 2022, its #43 holding.
  • Lloyd Park first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • 497 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2022.

Based on Lloyd Park's 13F filing for Q3 2022, filed 14 Nov 2022.